BMY · Bull vs Bear

The case for and the case against Bristol-Myers Squibb Company, each point drawn from public SEC filings — who’s buying, the red flags, and the health score. No opinion, no price call. Read both sides, then pick yours.

the bull case // 2

Strong financial strength

Piotroski F 7/9 (7 measured)

SEC XBRL

Strong cash position

self-funding

SEC XBRL

the bear case // 0

No red flags in the filing-based checks, and no one-sided insider selling. Absence of a flag is not a clean bill of health — filings lag 40–90 days.

where do you land on BMY?

Bull Bear

Saved on this device. Your call, from the evidence above — not a recommendation.

Educational only — not financial adviceand never a recommendation to buy or sell. Both sides are built from public SEC filings (Form 4, STOCK Act, 13F, XBRL financials), which lag 40–90 days; absence of a red flag is not a clean bill of health.